These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS). Imhof PR; Vuillemin T; Gérardin A; Racine A; Müller P; Follath F Eur J Clin Pharmacol; 1984; 27(1):7-12. PubMed ID: 6436032 [TBL] [Abstract][Full Text] [Related]
3. Effect of nitroglycerin on DL of normal subjects at rest and during exercise. Nemery B; Piret L; Brasseur L; Frans A J Appl Physiol Respir Environ Exerc Physiol; 1982 Apr; 52(4):851-6. PubMed ID: 6806224 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary vascular pressures of strenuously exercising Thoroughbreds during intravenous infusion of nitroglycerin. Manohar M; Goetz TE Am J Vet Res; 1999 Nov; 60(11):1436-40. PubMed ID: 10566823 [TBL] [Abstract][Full Text] [Related]
5. Relative bioavailability of a new transdermal nitroglycerin delivery system. Noonan PK; Gonzalez MA; Ruggirello D; Tomlinson J; Babcock-Atkinson E; Ray M; Golub A; Cohen A J Pharm Sci; 1986 Jul; 75(7):688-91. PubMed ID: 3093667 [TBL] [Abstract][Full Text] [Related]
6. Heating and cooling of the nitroglycerin patch application area modify the plasma level of nitroglycerin. Klemsdal TO; Gjesdal K; Bredesen JE Eur J Clin Pharmacol; 1992; 43(6):625-8. PubMed ID: 1493844 [TBL] [Abstract][Full Text] [Related]
7. [Transcutaneous transport of trinitrin in children after application of nitroglycerin patches]. Vaksmann G; Rey E; Francart C; Olive G; Dupuis C Presse Med; 1990 Dec; 19(42):1937-8. PubMed ID: 2147754 [TBL] [Abstract][Full Text] [Related]
8. [Interval therapy in effective treatment of angina pectoris using nitroglycerin patch systems. A controlled study with determination of nitroglycerin plasma levels]. Reiniger G; Menke G; Boertz A; Kraus F; Rudolph W Herz; 1987 Feb; 12(1):68-73. PubMed ID: 3104180 [TBL] [Abstract][Full Text] [Related]
9. Nitroglycerin absorption from transdermal systems: formulation effects and metabolite concentrations. Williams RL; Thakker KM; John V; Lin ET; Liang-Gee W; Benet LZ Pharm Res; 1991 Jun; 8(6):744-9. PubMed ID: 1905809 [TBL] [Abstract][Full Text] [Related]
10. Physical exercise increases plasma concentrations of nicotine during treatment with a nicotine patch. Klemsdal TO; Gjesdal K; Zahlsen K Br J Clin Pharmacol; 1995 Jun; 39(6):677-9. PubMed ID: 7654487 [TBL] [Abstract][Full Text] [Related]
12. [Acute effects of transdermal administration of nitroglycerin on effort tolerance and myocardial perfusion, evaluated by Tl-201 scintigraphy, in patients with stable effort angina]. Novo S; Liquori M; Abrignani MG; Giuliano F; Panno V; Fazio M; Adamo L; Corda M; Indovina A; di Maria G Cardiologia; 1991 Sep; 36(9):693-702. PubMed ID: 1802393 [TBL] [Abstract][Full Text] [Related]
13. The effect of continuous versus intermittent treatment with transdermal nitroglycerin on pacing-induced preconditioning in conscious rabbits. Szilvassy Z; Ferdinandy P; Nagy I; Jakab I; Koltai M Br J Pharmacol; 1997 Jun; 121(3):491-6. PubMed ID: 9179391 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of continuous and intermittent treatment with glyceryl trinitrate by the transdermal route in stable effort angina]. Bory M; Benaïch P; Panagides D; Desfossez L; Massiani PF; Bonnet JL Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):153-9. PubMed ID: 8054072 [TBL] [Abstract][Full Text] [Related]
16. [Discontinuous drug release as an alternative to interval therapy in the treatment of coronary heart disease with nitroglycerin patches]. Reiniger G; Rudolph W Herz; 1987 Oct; 12(5):348-53. PubMed ID: 3119443 [TBL] [Abstract][Full Text] [Related]
17. Nitroglycerin concentration in plasma: comparison between transdermal therapeutic system and ointment. Chu LC; Gale RM; Schmitt LG; Shaw JE Angiology; 1984 Sep; 35(9):545-52. PubMed ID: 6435484 [TBL] [Abstract][Full Text] [Related]
18. Transdermal nitroglycerin efficacy in patients with chronic stable angina pectoris as related to sympathetic and renin-angiotensin-aldosterone activity. Muiesan ML; Agabiti-Rosei E; Romanelli G; Beschi M; Castellano M; Cefis M; Cerri B; Pollavini G; Muiesan G Eur Heart J; 1992 Jan; 13(1):15-21. PubMed ID: 1577025 [TBL] [Abstract][Full Text] [Related]
19. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina]. Cianfrocca C; Sabia R; Zoboli S; Bugiardini R G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869 [TBL] [Abstract][Full Text] [Related]
20. [Sublingual nitroglycerin: the pharmacokinetic changes following long-term treatment with trinitrolong and nitroderm-TTS]. Blagodatskikh SV; Piotrovskiĭ VK; Metelitsa VI; Martsevich SIu; Riabokon' OS Farmakol Toksikol; 1991; 54(4):62-6. PubMed ID: 1786833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]